Gyre Therapeutics (GYRE) EBIT (2009 - 2026)
Gyre Therapeutics (GYRE) recorded EBIT of -$14.36 million in Q2 2026, compared with -$2.24 million a year earlier.
Powered by 
Analysis
Gyre Therapeutics (GYRE) EBIT (2009 - 2026) Analysis & Trends
On a TTM basis, Gyre Therapeutics' EBIT came in at -$16.68 million as of Jun 30, 2026; for FY2025, it was $11.49 million, down 28.9% from FY2024.
- Across earlier years, EBIT came in at $16.16 million in FY2024, -$67.23 million in FY2023, $9.2 million in FY2022 and -$87.89 million in FY2021.
- The Q2 2026 figure is the lowest quarterly EBIT since Q4 2023.
- On a year-over-year basis, EBIT rose in 1 of the last four quarters, with an average decline of 39.3%.
- Per Business Quant, the preceding three quarters came in at -$9.36 million (Q1 2026), $118,000 (Q4 2025) and $6.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn | -1.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1.52 Mn |
| Jun 30, 2026 | -14.36 Mn |
| Mar 31, 2026 | -9.36 Mn |
| Dec 31, 2025 | 9.69 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 665,000.00 |
| Sep 30, 2024 | 4.23 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 8.07 Mn |
| Dec 31, 2023 | -91.63 Mn |
| Sep 30, 2023 | 12.76 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 6.66 Mn |
| Dec 31, 2022 | -22.46 Mn |
| Sep 30, 2022 | -5.17 Mn |
| Jun 30, 2022 | 51.53 Mn |
| Mar 31, 2022 | -14.70 Mn |
| Dec 31, 2021 | -20.31 Mn |
API Access
Gyre Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();